The efifcacy and safety assessment of estradiol for treatment of women with perimenopausal syndrome
- VernacularTitle:雌二醇治疗妇女围绝经期综合征的疗效及安全性评估
- Author:
Caixia WANG
;
Ningshuang JI
;
Tingting CHEN
;
Juying LAI
- Publication Type:Journal Article
- Keywords:
estradiol;
women climacteric syndrome;
clinical efifcacy;
safety
- From:
Chinese Journal of Biochemical Pharmaceutics
2014;(2):81-83
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical efifcacy of estradiol on perimenopausal syndrome,and evaluate its safety. Methods 64 cases with perimenopausal syndrome collected in our hospital from January 2010 to January 2011 were used as observation group, and treated with Estradiol valerate. Another 64 cases during the same period were used as control group, and treated with conventional therapy. After treatment, the symptom improvement of both groups were evaluated by the scoring criteria of HAMD and Kupperman, and the related hormone levels were detected and recorded. Adverse reactions after treatment were also observed. Results Clinical results showed that the HAMD and Kupperman score of both groups in end of treatment were better than before treatment, and the improvement degree in observation group were better than control in. The differences were signiifcant (P<0.05). Test results showed that the improvement of various hormonal indicators in observation group were also better than that in control group, the diffierences were significant (P<0.05). 8 cases of adverse reactions were observed in observation group after treatment, 12 cases in control group. Adverse reactions included breast tenderness, vaginal bleeding and gastrointestinal discomfort. The side effects between both groups had no signiifcant difference. Conclusion The efifcacy of Estradiol on perimenopausal syndrome was obvious, it can improve the menopausal symptoms, with less adverse reactions, and improve the life quality of perimenopausal women.
